ProCE Banner Activity

Transcending Barriers, Transforming Outcomes: Improving HIV Care for Transgender People With HIV—Drs Beatriz Grinsztejn and Colleen Kelley

Video

On-demand webcast of expert faculty presentation and case discussion on strategies for improving the care of transgender people with HIV.

Released: August 22, 2024

Expiration: August 21, 2025

Share

Faculty

Beatriz Grinsztejn

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Colleen F. Kelley

Colleen F. Kelley, MD, MPH

Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Co-Director, Emory Center for AIDS Research
Associated Dean for Research, Emory at Grady
Emory University School of Medicine
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC in partnership with National Coalition for LGBTQ Health  

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

National Coalition for LGBTQ Health

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, nurses, and other healthcare professionals who provide care for people living with HIV.

Program Learning Goal

To improve learners’ competence in improving HIV outcomes in transgender people by overcoming barriers to care and addressing unique ART-related considerations.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Implement strategies to improve linkage and retention in HIV care and ART adherence for transgender people living with HIV

  • Provide gender-affirmative HIV care for transgender people living with

  • Individualize HIV care to optimize the overall health of key subpopulations of transgender people living with HIV, including younger, older, and minority individuals

Disclosure

Primary Author

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Beatriz Grinsztejn, MD, PhD: consultant/advisor: Gilead, Merck, ViiV.

Colleen F. Kelley, MD, MPH

Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Co-Director, Emory Center for AIDS Research
Associated Dean for Research, Emory at Grady
Emory University School of Medicine
Atlanta, Georgia

Colleen F. Kelley, MD, MPH: researcher: Gilead, Humanigen, Moderna, Novavax, ViiV.